and vascular resistance to decrease in the forearm and calf of human subjects ( I -3,8) . The changes are considered to be in the muscular bed since hand blood flow (representing skin) decreases during hyperventilation (I, 3, 8) . Whether the increase in blood flow represents an increase in capillary flow to muscle or flow shunted through arteriovenous channels has not been studied. concomitant decrease in skin circulation would also be consistent with the action of epinephrine (6). In the present investigation, the disappearance rate of a radioisotope injected into skeletal muscle was studied during hyperventilation to determine if the increase in blood flow was in skeletal muscle and if the blood flow was through capillary or through arteriovenous anastomotic channels. The effect of beta receptor blockade by propranolol on the blood flow response was also studied to determine if beta receptor stimulation was involved.
METHODS
Total calf blood flow was measured bY venous occlusion plethysmography on lightly clothed subjects lying in the supine position.
The subject's calf was slightly elevated and enclosed in a plethysmograph filled with water at a temperature of 34 C. This position maintained the posterior aspect of the lower leg approximately at heart level. The technic for enclosing the limb in the water plethysmograph has been described previously in detail (I 2 rates were recorded before, during, and after hyperventilation. Three control blood flows were obtained every 5 min until they became stable, and radioactive counts were followed for 5 to IO min to assure a linear disappearance rate. Subjects then hyperventilated at 30 moderately deep breaths per min (timed by a stopwatch).
A pneumotachograph around the subject's chest was used to record respiratory rate. In experiments in which subjects hyperventilated a gas mixture of 5 % carbon dioxide in oxygen, a mouthpiece, nose clamp, and two-way valve were used; this apparatus was also used for room air hyperventilation in these experiments. Ten subjects hyperventilated before and 45 min after an intravenous injection of I0 mg propranolol. Propranolol and epinephrine hydrochloride were injected via the tubing of a slow intravenous infusion of saline which ran throughout the experiment. Epinephrine was given by a constant-infusion pump at a rate of IO pg/ml per min for a 5-min period both before and 25 min after the propranolol injection.
. $P < 0.5.
Hyperventilation with room air. Hyperventilation produced an increase in calf blood flow in all but I of 17 subjects. Calf blood flow averaged 3.6 before hyperventilation and showed a significant increase to 5.8 ml/r oo ml per min during hyperventilation (Table   I) Figure  I depicts the plethysmographic calf blood flow and NaI 131 disappearance rate in one experiment. Total calf blood flow showed an initial large increase during hyperventilation followed by a smaller rise. The NaIr31 disappearance rate half-time of I 3. I min increased to 8.5 min during hyperventilation. Following hyperventilation, the half-time slowed to 16.5 min. Hyperventilation u&h 5 % COZ. Hyperventilation with a gas mixture of 5 70 CO2 in g5 70 oxygen did not produce a significant increase in calf blood flow or decrease in vascular resistance (Table   I) .
Five of the ten subjects showed no increase in calf blood flow, and four showed no decrease in resistance. Calf flow averaged 3.0 before and 3.5 ml/ I oo ml per min during hyperventilation for all IO Hyperuentilation with room air after propranolol. Ten subjects were given propranolol intravenously. A significant decrease occurred in calf blood flow which averaged 4.2 before and 3.5 ml/I oo ml per min after propranolol, but the increase in vascular resistance after propranolol to 26.8 from 23.8 units was not statistically significant (Table   2 ).
In a previous study, calf blood flow was found to decrease significantly as experiments progressed when only placebos were administered (5).
crease) propranolol; a significant difference was found (P < 0.05). Therefore the beta receptor blocker as used did attenuate the effect of hyperventilation on calf blood flow and vascular resistance.
The IO subjects also received intravenous epinephrine before and after propranolol to document blockade of beta receptors. Calf blood flow increased in all subjects during the 5-min epinephrine infusion before propranolol but decreased in all subjects after propranolol. Calf vascular resistance decreased an average of 7.7 units before as compared with an increase of 34.8 units after propranolol (P < 0.001). Therefore, beta receptor blockade appeared to be present in these experiments.
Significant decreases in calf vascular resistance and increases in calf blood flow occurred during hyperventilation both before and after the administration of propranolol (Table   2) .
Therefore, the beta receptor blocker as used did not prevent the vasodilatation caused by hyperventilation.
However, g of the IO subjects studied with calf flows showed a larger calf vascular resistance and a smaller blood flow during hyperventilation after, than before propranolol.
The calf vascular resistance during hyperventilation of I 7.7 units before propranolol was significantly different from the resistance of 2 2.5 units during hyperventilation after propranolol. Calf blood flow during hyperventilation before propranolol also differed significantly from the flow during hyperventilation after propranolol administration. Since calf blood flow had decreased during the course of the experiments, percentage change in blood flow during hyperventilation (hyperventilation blood flow divided by control blood flow X IOO) was also calculated and compared before (47.8 % increase) and after (26.0 % inFigures 3 and 4 depict two experiments in which the subjects hyperventilated room air and received intravenous epinephrine before and after propranolol. In both figures, it can be seen that, following propranolol administration, epinephrine produced vasoconstriction instead of vasodilatation.
After propranolol, a large rise in systemic mean blood pressure occurred during epinephrine infusions. In Fig. 3 it can be seen that propranolol produced little change in the increase in calf blood flow which occurred during hyperventilation; in Fig. 4 , a definite attenuation is seen. Systemic blood pressure changes during hyperventilation averaged an increase of 5 mm Hg before propranolol and 3.9 mm Hg after propranolol; there was no significant difference (P < 0.4). the arm being injected. Hyperventilation usually caused a lightheaded feeling and paresthesia in the digits both before and after propranolol.
DISCUSSION
In the present and previous studies (I -3, 8) , hyperventilation produced a significant increase in plethysmographic calf and forearm blood flow. The increase in the disappearance of NaI 131 from the calf muscle during hyperventilation demonstrates that the increase in blood flow occurs in muscle. Previously, it was surmised that the increase in calf or forearm blood flow was in the muscular bed since skin (hand) blood flow (I, 3, 8) There has also been a difference in the reported findings regarding cardiac output (2, 9). Therefore, it would be difficult to explain the increase in muscle blood flow by a change in blood pressure or cardiac output in all studies.
In the present and previous studies (3, 8), hyperventilation using 5 7% carbon dioxide induced no change or smaller increases in muscle blood flow than hyperventilation with room air. Therefore the increase in blood flow cannot be entirely a consequence of intrathoracic pressure changes and must be related in part to the resulting hypocapnia. The hypocapnia could produce its effect via the nervous system, by a direct vascular effect, or by release of a humoral substance. During hyperventilation with room air, alveolar carbon dioxide is lowered (3), arterial pH rises, and carbon dioxide tension decreases (7). Since an increase in forearm and a decrease in hand blood flow occur during hyperventilation even after nerve block or sympathectomy of the arm (2, 8) , the muscle vasodilatation and cutaneous vasoconstriction presumably are not effected via the nervous system. Locally, low carbon dioxide tension with an increased pH produces muscle vasodilatation (7); the local effect of low carbon dioxide tension with no change in pH is not known.
Since vasoconstriction occurs in the skin during hyperventilation, any chemical change in the blood responsible for the vascular changes would have to affect skin and muscle blood vessels differently.
The release of epinephrine from the adrenal medulla by hypocapnia would cause cutaneous vasoconstriction and muscle vasodilatation.
Clarke (3) first commented on the remarkable similarity of the forearm blood flows during hyperventilation to the blood flow increases produced by intravenous epinephrine (a large initial vasodilatation followed by a lesser increase in blood flow). Although the vasodilator effect of epinephrine was effectively blocked in the present experiments, propranolol failed to block completely the increase in muscle blood flow during hyperventilation.
Significant, sizeable increases in blood flow and decreases in vascular resistance still occurred. However, propranolol did cause small but significant attenuation of the effect of hyperventilation on muscle blood flow and vascular resistance and therefore, it could be argued that epinephrine or another beta receptor stimulator might be involved in the response. 
